PASG — Passage Bio Cashflow Statement
0.000.00%
Last trade - 00:00- $20.46m
- -$56.30m
- 11
- 53
- 20
- 17
Annual cashflow statement for Passage Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -112 | -185 | -136 | -102 | -64.8 |
| Depreciation | |||||
| Non-Cash Items | 16.5 | 45.5 | 22.7 | 14.7 | 9.53 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 14.4 | 11.4 | -8.49 | 5.34 | 4.2 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -80.5 | -127 | -118 | -78.3 | -48 |
| Capital Expenditures | -1.65 | -25.6 | -5.27 | -0.146 | -0.034 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -170 | -20.2 | 30.5 | 65.4 | 55 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -172 | -45.8 | 25.2 | 65.2 | 54.9 |
| Financing Cash Flow Items | — | -0.338 | -1.79 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 229 | 167 | -1.35 | 0.135 | 8.87 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -23.9 | -6.04 | -94.4 | -12.9 | 15.9 |